Drug Type Small molecule drug |
Synonyms 1,2,3,4,6-Pentakis-O-Galloyl-β-D-Glucopyranoside |
Mechanism ACE2 inhibitors(Angiotensin-converting enzyme 2 inhibitors), SARS-CoV-2 S protein inhibitors(Coronavirus spike glycoprotein inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
COVID-19 | Preclinical | US | 01 Dec 2024 |